©istock.com/Andrea Obzerova
Interdisciplinary CompetenceMolecular Diagnostics
Know how in the analysis of genetic material.
For the benefit of patients.

IllnessDiabetes mellitus, MODY; differential diagnosis

Summary

Short information

Comprehensive differential diagnostic panel for Diabetes mellitus, MODY comprising 6 guideline-curated, 5 core candidate genes and altogether 29 curated genes according to the clinical signs

ID
DP0010
Number of genes
16 Accredited laboratory test
Examined sequence length
16,7 kb (Core-/Core-canditate-Genes)
28,2 kb (Extended panel: incl. additional genes)
Analysis Duration
on request
Material
  • EDTA-anticoagulated blood (3-5 ml)
Diagnostic indications

NGS +

[Sanger]

 

Gene panel

Selected genes

NameExon Length (bp)OMIM-GReferenz-Seq.Heredity
ABCC84746NM_000352.6AD, AR
APPL12129NM_012096.3AD
GCK1398NM_000162.5AD, AR
HNF1A1896NM_000545.8AD
HNF1B1674NM_000458.4AD
HNF4A1359NM_175914.4AD
INS333NM_000207.3AD
KCNJ111173NM_000525.4AD
NEUROD11071NM_002500.5AD, AR
PDX1852NM_000209.4AR
BLK1518NM_001715.3AD
INSR4149NM_000208.4AD
KLF111539NM_003597.5AD
LMNA1995NM_170707.4AD
PAX41056NM_001366110.1AD
PAX61269NM_000280.5AD

Informations about the disease

Clinical Comment

MODY is the most common form of monogenic diabetes. The clinical features of MODY vary according to genetic aetiology. Most common subtypes are HNF1A-MODY (30-50%), GCK-MODY (30-50%), HNF4A-MODY (10%) and HNF1B-MODY (1-5%). The latter is also known as kidney cysts and diabetes syndrome. At least nine other less common genetic subtypes have been described. Patients with HNF1A and HNF4A mutations have slowly progressive beta cell dysfunction. Vascular complications of diabetes are observed with a similar frequency to type 1 or type 2 diabetes. GCK-associated MODY is characterised by asymptomatic, non-progressive mild fasting hyperglycaemia with low postprandial glucose excursions from birth and is not associated with vascular complications. Indications for genetic testing for MODY include the occurrence of diabetes in adolescence or young adulthood, maintenance of endogenous insulin production and usually a significant family history of diabetes. Inheritance is usually autosomal dominant; penetrance values vary according to mutated genes.

Reference: https://www.ncbi.nlm.nih.gov/books/NBK500456/

 

Synonyms
  • APPL1, BLK, KLF11, PAX4: evidence for causing MODY needs to be expanded/confirmed
  • Allelic: Allelic: Ventricular septal defect 1 (GATA4)
  • Allelic: Aniridia (PAX6)
  • Allelic: Anterior segment dysgenesis 5, multiple subtypes (PAX6)
  • Allelic: Atrial septal defect 2 (GATA4)
  • Allelic: Atrial septal defect 9 (GATA6)
  • Allelic: Atrioventricular septal defect 4 (GATA4)
  • Allelic: Atrioventricular septal defect 5 (GATA6)
  • Allelic: Cardiomyopathy, dilated, 1A (LMNA)
  • Allelic: Carotid intimal medial thickness 1 (PPARG)
  • Allelic: Cataract 41 (WFS1)
  • Allelic: Cataract with late-onset corneal dystrophy (PAX6)
  • Allelic: Charcot-Marie-Tooth disease, type 2B1 (LMNA)
  • Allelic: Coloboma of optic nerve (PAX6)
  • Allelic: Coloboma, ocular (PAX6)
  • Allelic: Colorectal cancer, susceptibility to, 10 (POLD1)
  • Allelic: Deafness, AD 6/14/38 (WFS1)
  • Allelic: Diabetes mellitus, insulin-dependent (HNF1A)
  • Allelic: Diabetes mellitus, insulin-dependent, 20 (HNF1A)
  • Allelic: Diabetes mellitus, ketosis-prone, susceptibility to (PAX4)
  • Allelic: Diabetes mellitus, noninsulin-dependent (ABCC8, HNF1B, HNF4A)
  • Allelic: Diabetes mellitus, noninsulin-dependent, 2 (HNF1A)
  • Allelic: Diabetes mellitus, noninsulin-dependent, late onset (GCK)
  • Allelic: Diabetes mellitus, permanent neonatal (ABCC8, GCK, INS)
  • Allelic: Diabetes mellitus, permanent neonatal, with neurologic features (KCNJ11)
  • Allelic: Diabetes mellitus, transient neonatal 2 (ABCC8)
  • Allelic: Diabetes mellitus, transient neonatal, 3 (KCNJ11)
  • Allelic: Diabetes mellitus, type 1 (INS)
  • Allelic: Diabetes mellitus, type 2 (PAX4)
  • Allelic: Diabetes mellitus, type 2, susceptibility to (KCNJ11, PDX1, NEUROD1)
  • Allelic: Emery-Dreifuss muscular dystrophy 2, AD (LMNA)
  • Allelic: Emery-Dreifuss muscular dystrophy 3, AR (LMNA)
  • Allelic: Foveal hypoplasia 1 (PAX6)
  • Allelic: Heart-hand syndrome, Slovenian type (LMNA)
  • Allelic: Hepatic adenoma, somatic (HNF1A)
  • Allelic: Hyperinsulinemic hypoglycemia, familial, 1 (ABCC8)
  • Allelic: Hyperinsulinemic hypoglycemia, familial, 2 (KCNJ11)
  • Allelic: Hyperinsulinemic hypoglycemia, familial, 3 (GCK)
  • Allelic: Hyperproinsulinemia (INS)
  • Allelic: Hypoglycemia of infancy, leucine-sensitive (ABCC8)
  • Allelic: Keratitis (PAX6)
  • Allelic: Lipodystrophy, familial partial, type 3 (PPARG)
  • Allelic: Malouf syndrome (LMNA)
  • Allelic: Mandibuloacral dysplasia (LMNA)
  • Allelic: Morning glory disc anomaly (PAX6)
  • Allelic: Muscular dystrophy, congenital (LMNA)
  • Allelic: Obesity, resistance to (PPARG)
  • Allelic: Obesity, severe (PPARG)
  • Allelic: Optic nerve hypoplasia (PAX6)
  • Allelic: Pancreatic agenesis 1 (PDX1)
  • Allelic: Pancreatic agenesis and congenital heart defects (GATA6)
  • Allelic: Persistent truncus arteriosus (GATA6)
  • Allelic: Renal cell carcinoma (HNF1A, HNF1B)
  • Allelic: Renal cysts and diabetes syndrome (HNF1B)
  • Allelic: Restrictive dermopathy 2 (LMNA)
  • Allelic: Testicular anomalies +/- congenital heart disease (GATA4)
  • Allelic: Tetralogy of Fallot (GATA4)
  • Allelic: Tetralogy of Fallot (GATA6)
  • Diabetes Mellitus, noninsulin-dependent, with acanthosis nigricans + hypertension (PPARG)
  • Diabetes [panelapp] (PAX6)
  • Diabetes mellitus [MONDO:0005015, panelapp] (ZBTB20)
  • Diabetes mellitus, insulin-resistant, with acanthosis nigricans (INSR)
  • Diabetes mellitus, noninsulin-dependent, association with (WFS1)
  • Diabetes, type 2 (PPARG)
  • Donohue syndrome (INSR)
  • Fanconi renotubular syndrome 4, with MODY (HNF4A)
  • Histiocytosis-lymphadenopathy plus syndrome (SLC29A3)
  • Hutchinson-Gilford progeria (LMNA)
  • Hyperinsulinemic hypoglycemia, familial, 5 (INSR)
  • Hyperphenylalaninemia, BH4-deficient, D (PCBD1)
  • Insulin resistance, severe, digenic (PPARG)
  • Lipodystrophy, familial partial, type 2 (LMNA)
  • Lipodystrophy, familial partial, type 4 (PLIN1)
  • MODY, type I (HNF4A)
  • MODY, type II (GCK)
  • MODY, type III (HNF1A)
  • MODY, type IV (PDX1)
  • MODY, type IX (PAX4)
  • MODY, type VI (NEUROD1)
  • MODY, type VII (KLF11)
  • MODY, type VIII (CEL)
  • MODY, type X (INS)
  • MODY, type XI (BLK)
  • MODY, type XIII (KCNJ11)
  • MODY, type XIV (APPL1)
  • Mandibular hypoplasia, deafness, progeroid features + lipodystrophy syndrome (POLD1)
  • Microcephaly, short stature, and impaired glucose metabolism 1 (TRMT10A)
  • Mitchell-Riley s.: neonat. diab., pancreatic hypopl., intest. atresia, gallbladder a-/hypopl. (RFX6)
  • Neonatal diabetes mellitus [MONDO:0016391, panelapp] (GATA6)
  • Pancreatic agenesis and congenital heart defects (GATA6)
  • Pancreatic hypoplasia-diabetes-congenital heart disease syndrome [MONDO:0010802, panelapp] (GATA4)
  • Permanent neonatal diabetes melllitus [MONDO:0100164, panelapp] (GATA4)
  • Pigmented hypertrichotic dermatosis with insulin-dependent diabetes, PHID syndrome (SLC29A3)
  • Primrose syndr.: special face, macroceph., ID, calcified ears, sparse hair, muscle wasting (ZBTB20)
  • Rabson-Mendenhall syndrome (INSR)
  • Transient neonatal diabetes mellitus [MONDO:0020525, panelapp] (GATA4)
  • Wolfram syndrome 1 (WFS1)
  • Wolfram syndrome 2 (CISD2)
  • Wolfram-like syndrome, AD (WFS1)
Heredity, heredity patterns etc.
  • AD
  • AR
OMIM-Ps
  • Multiple OMIM-Ps
ICD10 Code

Bioinformatics and clinical interpretation

No text defined